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Abstract
© Saint Petersburg Pasteur Institute. All rights reserved. H. pylori is a Gram-negative, crimp and
motile bacterium that colonizes the hostile microniche of the human stomach roughly one half
of the human population. Then persists for the host's entire life, but only causes overt gastric
disease in  a  subset  of  infected hosts.  To the reasons contributing to  the development  of
diseases,  usually  include:  concomitant  infections  of  the  gastrointestinal  tract,  improper
sterilization of medical instruments, usually endoscopes, nonobservance of personal hygiene
rules, prolonged contact with infected or carriers, including family members and a number of
other factors. Clinically, H. pylori plays a causative role in the development of a wide spectrum
of  diseases  including  chronic  active  gastritis,  peptic  and  duodenal  ulceration,  gastric
adenocarcinoma, and gastric mucosa-associated lymphoid tissue lymphoma. Due to the global
distribution of H. pylori,  we are able to conclude that smart strategies are contributing to
adaptation of the bacterium in an aggressive environment of a stomach and lifelong permanent
circulation in its host. Thirty-four years after the discovery of this bacterium, there are still many
unanswered questions. For example, which strategies help the bacterium to survive in this
inhospitable conditions? Understanding the mechanisms governing H. pylori  persistence will
improve identification of the increased risk of different gastric diseases in persons infected with
this bacterium. A well-defined and long-term equilibrium between the human host and H. pylori
allows bacterial persistence in the gastric microniche; although this coexistence leads to a high
risk of severe diseases the diseases which are listed above. In this review, we discuss the
pathogenesis of this bacterium and the mechanisms it uses to promote persistent colonization
of the gastric mucosa, with a focus on recent insights into the role of some virulence factors like
urease, LPS, outer membrane proteins, cytotoxins, factors, promoting invasion. Information on
the mechanisms related to  H.  pylori  persistence can also  provide the direction  for  future
research concerning effective therapy and management of gastroduodenal disorders. The topics
presented in the current review are important for elucidating the strategies used by H. pylori to
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